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http://dx.doi.org/10.1016/j.pedneo.2Background: In order to reduce the unnecessary use of and provide appropriate guidance for
the administration of antibiotics, the neonatal bacterial infections screening score (NBISS)
was developed to assess each new patient that is admitted to the neonatal intensive care unit
(NICU).
Methods: NBISS was designed based on maternal risk factors, clinical presentations, and labo-
ratory data. The total score of each new patient is calculated at the time of admission. The
first period of this study was an observational survey. Receiver operating characteristic
(ROC) curves were used to determine the best cut-off NBISS for the diagnosis of bacterial infec-
tion (BI) and guide the use of antibiotics during the second period of this study.
Results: Of 250 neonates who were admitted to the NICU, 237 (94.8%) received antibiotics
during the first period of study. The initial total scores were not statistically different
between the BI and non-BI groups (p Z 0.155). We weighted C-reaction protein (CRP) (by
8), the presence of a bulging fontanelle, pus from the ear canal, redness around the umbi-
licus, reduced movement, and being unable to feed (each by 5) as significantly different
between the BI and non-BI groups (p Z 0.015). Weighted scores >8 points demonstrated
the best diagnostic accuracy for indicating BI. After introducing NBISS for predicting BI in
new patients admitted to NICU, the rate of antibiotic use significantly decreased from
94.8% to 60.3% between the two periods.of Pediatrics, Kaohsiung Medical University Hospital, Number 100, Tzyou 1st Road, Kaohsiung City
org.tw (H.-L. Chen).
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246 Y.-N. Yang et alConclusion: Using this simple screening strategy, we were able to clinically reduce the use of
unnecessary antibiotics.
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reserved.1. Introduction
Newborn infants are uniquely susceptible to infectious
diseases, especially bacterial infections (BI). Serious BI in
newborns is the main cause of mortality and morbidity,
including sepsis, bacteremia, bacterial meningitis, urinary
tract infections, pneumonia, and bacterial gastroenteritis.1
In developing countries, the incidence of neonatal sepsis is
about 3.5e4.3 cases per 1000 live births.2,3 Due to their
immature immune systems, premature infants face higher
rates of infection. Therefore, early diagnosis and the rapid
administration of antibiotics to sick newborns are necessary
in such situations. However, accurately identifying and
distinguishing BI from non-BI cases in newborns remains
a difficult problem for physicians. As a result, there is a high
rate of the use of antibiotics to treat sick newborns in the
neonatal intensive care unit (NICU).4,5 Nevertheless, only
a minority of treated newborns actually has BI. This could
cause an increase in antibiotic-resistant bacteria and
healthcare costs.6e8
The risk factors associated with neonatal BI include low
gestational age, low birth weight, premature or prolonged
(>18 hours) rupture of membranes, maternal peripartum
fever, chorioamnionitis, meconium-stained amniotic fluid,
and resuscitation at birth.9,10 Neonates with BI may develop
tachypnea, severe chest retraction, nasal flaring, grouting,
convulsions, bulging fontanelle, fever, feeding intolerance,
and other clinical signs.11 Unfortunately, the symptoms and
signs in newborns with BI are nonspecific and non-
localized.5,12 The gold standard for the diagnosis of BI is
isolating bacteria from sterile sites (e.g., blood, cerebro-
spinal fluid [CSF], urine, closed body space). However, the
results of bacterial cultures are usually unavailable over the
short term. Other laboratory data on neonates with BI may
reveal leukocytosis, increased immature-to-total neutro-
phil (I/T) ratio, and an elevated C-reaction protein (CRP)
level. However, these results are not specific to the early
stages of newborns with BI. Other possible markers for BI,
such as interleukin (IL)-6, IL-8, tumor necrosis factor-alpha
(TNF-a), interferon gamma (INF-g), and procalcitonin (PCT)
show promising results for the early diagnosis of BI, but
these assays are expensive and time-consuming.5,11,13
Therefore, there is no specific marker suitable for the
early diagnosis of newborns with BI.
In order to reduce the rate of antibiotics use in the NICU,
we developed an objective and reliable scoring tooldthe
neonatal bacterial infections screening score (NBISS)dfor
assessing newborns with BI. This scoring tool integrates
maternal risk factors, clinical presentation, and laboratory
data of the patients who are newly admitted to the NICU.
The goal of this study is to establish cut-off values for NBISS
that can be used to guide the use of antibiotics in patients
who are newly admitted to the NICU. Furthermore, theresults of this study could also reduce healthcare costs and
the emergence of multiple drug-resistant bacterial strains
that are the result of the overuse of antibiotics.
2. Materials and Methods
2.1. Observation period
All neonates (<28 postnatal days) who were newly
admitted to the NICU of Kaohsiung Medical University
Hospital during the observation period from January 1, 2009
through December 31, 2009 were enrolled. Clinical data
were collected on the first day of admittance to the NICU.
The NBISS was designed to incorporate maternal risk
factors, clinical presentation, and laboratory data. A total
of 25 items are taken into account when calculating NBISS.
The items included as maternal risk factors include
premature or prolonged (>18 hours) rupture of membranes,
maternal peripartum fever, positive maternal group B
streptococcus (GBS) screening, maternal pyuria, and
meconium-stained amniotic fluid or chorioamnionitis.
Clinical presentation includes 15 items: respiratory rate
>60 breaths/minute, severe chest retraction, nasal flaring,
grunting, convulsions, bulging fontanelle, pus draining from
the ear, redness around the umbilicus, temperature
>37.7C or <35.5C, lethargy or unconsciousness or
reduced movements, inability to feed, inability to suckle at
all, cyanosis, reduced digital capillary refill time, and
shock. Laboratory data consists of five items, including
leukocytosis or leukopenia, I/T ratio > 0.2, CRP > 6 mg/L,
IgM > 20 mg/dL, and the need to undergo a CSF study due
to the patient’s clinical condition. Each positive item added
1 point to the total NBISS score. The total score of each new
patient was calculated upon admission.
The BI group was defined by a positive blood culture,
positive urine culture, and a positive CSF culture or pneu-
monia, which was diagnosed by chest X-ray. Patients were
excluded if they had a) a major congenital anomaly, b)
obvious surgical indications (e.g., imperforate anus), or c)
detailed laboratory data could not be collected. The best
NBISS cut-off value for the diagnosis of BI and deciding to
use antibiotics was determined using receiver operating
characteristic (ROC) curve analysis according to the patient
scores obtained during the observation period.
2.2. Interventional period
The interventional period lasted from January 1, 2010
through December 31, 2010. During this period, it was
suggested that any patient who was newly admitted to the
NICU with a score greater than the cut-off value for NBISS
(calculated during the observation period) be prescribed
Figure 2 Screenings, exclusions, and the diagnoses of BI
during the observation period.
Strategy for reducing of antibiotic use 247antibiotics. Physicians were able to adjust their clinical
decisions according to this guideline.
2.3. Statistical analysis
Statistical analyses were performed using JMP (version 8)
statistical discovery software from SAS (SAS Institute Inc.,
North Carolina, USA). The Chi-square test was used to
analyze categorical data and/or the t test was used for
numerical data. The Fisher exact test was performed if the
expected value was <5 in 2  2 contingency table. ROC
curve analysis was used to define the cut-off value for the
BI group. A two-tailed p value <0.05 was considered
statistically significant.
3. Results
During the observation period, 254 neonates were admitted
to our NICU. Of these, four patients were excluded
(Figure 2). The evaluated items of the NBISS and the
baseline characteristics of the remaining 250 sick neonates
are shown in Table 1.Twenty-nine (11.6%) of the study
participants presented with evidence of BI. Twenty-six of
29 patients were diagnosed with pneumonia by chest X-ray.
Two patients were diagnosed with meningitis due to
a positive CSF culture, and one had a positive urine culture.
There were higher percentages of positive maternal GBS
screens and maternal pyuria in the BI group than the non-BI
group. Regarding the items used to evaluate each patient’s
clinical presentation, only convulsions, bulging fontanelle,
pus draining from the ear, and redness around the umbilicus
showed significant differences between groups. Laboratory
data showed that the CRP level was significantly higher in
the BI group, but not leukocytosis or the I/T ratio. The rates
of antibiotics use upon admission were >90% in both groups
(Table 1). The total original NBISS between the two groups
did not show significant differences, although the BI group
had a higher mean score (4.2  2.7 vs. 3.7  2.3,
p Z 0.155). ROC curve analysis revealed that the area
under the curve (AUC) was 0.54 (Figure 1A). In order to
improve the accuracy of this scoring system, modification
by weighting the more important clinical items was per-
formed. CRP was the most statistically significant item
associated with BI. Therefore, we weighted CRP by 8 inFigure 1 (A) Observation period. Before the selected items w
Observation period. After the selected items were weighted, the AU
were weighted, the AUC was 0.73.order to guide antibiotics use. Otherwise, bulging fonta-
nelle, pus from the ear canal, redness around the umbi-
licus, reduced movements, and inability to feed (which are
significant and critical in clinical settings) were chosen for
their importance to bacterial infections in clinical setting.
We then weighted from 2, then 3 through 8, in order to
find the best diagnostic accuracy of this scoring system. In
the end, CRP was weighted by 8 and each of the other five
clinical items was weighted by 5. After weighting, the
NBISS of the BI group was significantly higher than that of
the non-BI group (7.5  6.1 vs. 5.3  4.7, p Z 0.015), and
the AUC reached 0.60 (Figure 1B). The best cut-off value
between the BI and non-BI groups that was calculated using
ROC curve analysis was 8 points. Weighted scores > 8 points
demonstrated the best accuracy for diagnosing BI. There-
fore, a new patient with a weighted NBISS score > 8 points
was recommended to receive antibiotics during the inter-
ventional period. Using this strategy of weighted scoring, 13
of 187 neonates (NBISS < 8 points) were not prescribed
antibiotics and did demonstrated favorable outcomes.
During the interventional period, a total of 264 neonates
were included (9 patients were excluded; Figure 3). The
clinical characteristics of both groups during the interven-
tional period are shown in Table 2. Sixteen (6.3%) of the
remaining 255 neonates were diagnosed with BI. Five of 16
BI patients with a weighted NBISS < 8 points were
prescribed antibiotics due to positive chest X-ray findings.ere weighted, the area under the curve (AUC) was 0.55. (B)
C was 0.60. (C) Interventional period. After the selected items
Table 1 Baseline characteristics of neonate screening in the observational period.
BI (n Z 29) Non-BI (n Z 221) p value
Characteristics
Sex, Male (%) 20 (68.9) 125 (56.5) 0.203
Gestational age, wk, mean  SD 37.3  2.4 35.0  3.5 <0.001*
Prematurity, n (%) 9 (31.0) 137 (61.2) 0.002*
BBW, g, mean  SD 2827  594 2306  778 <0.001*
Admitted age, days, mean  SD 3.8  5.5 1.6  1.8 <0.001*
Maternal risk factors, n (%)
PROM >18 hr 2 (6.9) 30 (13.6) 0.308
Maternal fever 2 (6.9) 5 (2.2) 0.312
Maternal GBS screen positive 4 (13.8) 5 (2.2) 0.002*
Maternal pyuria 2 (6.9 ) 3 (1.3) 0.045*
Meconium-stained amniotic fluid or chorioamnionitis 4 (13.8) 11 (4.9) 0.112
Clinical presentations, n (%)
Respiratory rate >60 breaths/min 23 (79.3) 171 (77.3) 0.814
Severe chest retraction 9 (31.0) 97 (43.3) 0.188
Nasal flaring 15 (51.7) 138 (62.4) 0.265
Grunting 8 (27.6) 97 (43.9) 0.094
Convulsions 2 (6.9) 3 (1.36) 0.045*
Bulging fontanelle 2 (6.9) 0 (0) <0.001*
Pus draining from the ear 1 (3.4) 0 (0) 0.006*
Redness around umbilicus 1 (3.4) 0 (0) 0.006*
Temperature >37.7C or <35.5C 2 (6.9) 5 (2.2) 0.155
Lethargic or unconscious or reduced movements 1 (3.4) 24 (10.8) 0.211
Not able to feed 1 (3.4) 34 (15.3) 0.082
No suckling at all 1 (3.4) 15 (6.7) 0.490
Cyanosis 5 (17.2) 37 (16.7) 0.946
Reduced digital capillary refill time 3 (10.3) 13 (5.8) 0.356
Shock 1 (3.4) 8 (3.62) 0.963
Laboratory data, n (%)
Leukocytosis or leukopenia 5 (17.2) 40 (18.1) 0.910
Immature neutrophil/total neutrophil (I/T ratio) >0.2 7 (24.1) 38 (18.3) 0.458
CRP > 6 mg/L 9 (31.0) 15 (6.7) <0.001*
IgM > 20 mg/dL 2 (7.6) 7 (3.1) 0.254
CSF study 11 (37.9) 34 (13.6) 0.003*
Disease at admission, n (%)
Respiratory distress 20 (68.9) 183 (82.8) 0.073
Meconium aspiratory syndrome 2 (6.9) 7 (3.17) 0.311
Sepsis 6 (20.6) 21 (9.5) 0.068
Others* 1 (3.4) 9 (4.07) 0.872
Antibiotic used, n (%) 28 (96.55) 212 (94.6) 0.661
Original score, mean  SD 4.24  2.7 3.7  2.3 0.156
Weighted score, mean  SD 7.5  6.1 5.3  4.7 0.015*
NBISS included three parts: maternal risk factors (5 items), clinical presentation of the neonate (15 items), and laboratory data
(5 items).
* One neonate was diagnosed with jaundice, 1 with hypoglycemia, 2 with gastrointestinal (GI) problems, 1 with bradycardia, 2 with
birth injuries, 1 with seizure, 1 with intrauterine growth retardation, and 1 was suspected of having congenital heart disease.
248 Y.-N. Yang et alThree of 16 neonates were diagnosed with meconium
aspiration syndrome; these neonates did not receive anti-
biotics and spontaneously improved following respiratory
support using nasal continuous positive airway pressure.
Diagnostic accuracy based on the use of weighted NBISS was
acceptable during this period, for which the AUC reached
0.73 (Figure 1C). After introducing NBISS for predicting BI in
new patients admitted to the NICU, the rate of antibiotics
use significantly decreased from 94.8% to 60.3% (Table 3)between these two periods. No unfavorable outcomes were
noted during this period.4. Discussion
In this study, we found that using the NBISS of each new
patient admitted to the NICU as a guide for antibiotics use
could significantly reduce unnecessary use.
Figure 3 Screenings, exclusions, and the diagnoses of BI
during the interventional period.
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for using antibiotics in the NICU. In neonatal and pediatric
intensive care units, antibiotic therapy is used in as many
as 80% of patients, with an average of about 50%4;
however, only a minority of patients actually have true BI.
During the observation period of this study, the rate of
antibiotics use was 94.8%, but the actual BI rate was low
(6.2%). There was a large discrepancy between the rate of
antibiotics use and the actual BI rate in this study. This
finding implies that many sick neonates are prescribed
unnecessary antibiotics on admission. The high rate of
unnecessary antibiotics could lead to an increase in
antibiotic-resistant bacterial strains, but untreated BI may
result in an increase in mortality and morbidity in sick
neonates.14,15 Therefore, in order to avoid the overuse of
antibiotics in neonates, many diagnostic tools and
biomarkers for neonatal sepsis have been developed and
reported.11,13,16
The biomarkers that are currently in use in clinical
settings include the total leukocyte count, I/T ratio, and
CRP level. Unfortunately, these biomarkers do not afford
a guaranteed diagnosis of neonatal BI. The total leukocyte
count does not have enough sensitivity or specificity to
make an early diagnosis of BI.17 An I/T ratio > 0.2 has been
proposed as a predictor of BI, however many non-BI
conditions are associated with an elevated I/T ratio, such
as maternal hypertension, maternal fever, perinatal
asphyxia, hypoglycemia, and hemolytic disease.18 The
specificity of the I/T ratio is fair (range: 0.75e0.91), but its
sensitivity is poor (range: 0.22e0.47)19; these values are
not high enough for the early diagnosis of BI in neonates.
CRP has been widely discussed and used in clinical settings
in recent decades. The sensitivity and specificity of CRP for
the diagnosis of BI are better than those of the I/T ratio and
total white blood cell count. CRP rises to maximum levels
after a 12e24-hour septic stimulus.15 Our analysis revealed
that CRP was the most sensitive item for diagnosing BI
during the observation period (p < 0.001) compared with
the other items. Unfortunately, the sensitivity of CRP has
been reported to vary from 35e65%.20e22 CRP alone is
insufficient for the early diagnosis of neonatal BI. Some
experts have suggested that IL-6, IL-8, and PCT may be
more useful for the diagnosis of BI in sick neonates than
CRP,13,23 but these are not popular in clinical settingsbecause of its high cost and time required to perform the
tests. Clinical signs such as tachypnea, changes in
consciousness, and feeding problems are usually associated
with BI, but these demonstrate low specificity for predict-
ing BI. In a study on neonatal sepsis in developing countries,
Weber et al reported that there is limited specificity for
using physical signs to identify young infants who are at risk
of neonatal sepsis.11 Therefore, the use of common labo-
ratory data in combination with clinical presentations and
maternal risk factors may be an efficient and cheap way to
quickly identify BI in sick neonates. These are the reasons
why we developed NBISS for evaluating new patients who
have been admitted to the NICU. This is the first study to
combine maternal risk factors, clinical presentations of
suspected BI, and abnormal laboratory data for the
prediction of BI.
The significant items included in the NBISS that were
associated with the neonatal BI group were positive
maternal GBS screen, maternal pyuria, convulsions, bulging
fontanelle, pus draining from the ear, redness around the
umbilicus, and CRP level. The original total scores of the
NBISS did not yield good results for differentiating BI from
non-BI. Bulging fontanelle, pus draining from the ear,
redness around umbilicus, and inability to feed were
selected for weighting because they were significantly
different between the BI and non-BI groups.11,12 Regarding
the items included in the laboratory data, CRP was also
a significant biomarker associated with BI in this study, so
we weighted these items in order to elevate the sensitivity
and specificity for differentiating the BI and non-BI groups.
Following these steps, the AUC was able to reach 0.60.
During the interventional period, we kept observing the
weighted items for their appropriateness and found that
a weighted NBISS score > 8 points could be used to properly
make a decision regarding the administration of antibiotics
to newly admitted neonates. The goal of this study was not
to determine the correlation between neonatal BI and the
rate of antibiotics use, but rather to create proper guide-
lines for clinicians to use when prescribing antibiotics to
new patients who have been admitted to the NICU. Based
on the findings of this study, NBISS may be a suitable and
simple guideline for use in our NICU.
It is important to note that there were four cases in the
BI group that were not administered antibiotics because
their NBISS scores were <8 points (1 case in the observation
period and 3 cases in the interventional period). All four of
these patients were diagnosed with meconium aspiratory
syndrome by chest X-ray. The role of routine antibiotic use
for the management of meconium aspiration syndrome
remains controversial. Lin et al24 conducted a prospective,
randomized, controlled clinical trial in 2005 to compare
infection-related outcomes of nonventilated cases of
meconium aspiration syndrome who presented without
perinatal risk factors for infection. Because treatment with
antibiotics did not affect the clinical courses or outcomes
related to infection in cases of meconium aspiration
syndrome without perinatal risk factors, treatment with
antibiotics should not be routine for every infant with
meconium aspiration syndrome. The report by Basu et al25
presented similar findings. Therefore, NBISS could be
additional tool to help clinicians decide whether antibiotic
treatment is necessary in such situations.
Table 2 Baseline characteristics of neonate screening in the second period.
BI (n Z 16) Non-BI (n Z 239) p value
Characteristics
Sex, Male (%) 11 (68.7) 139 (58.2) 0.405
Gestational age, wk, mean  SD 37.2  3.7 36.1  3.2 0.009*
Prematurity, n (%) 4 (25 ) 112 (46.4) 0.002*
BBW, g, mean  SD 290 5  825 256 9  73 1 0.039*
Admitted age, days, mean  SD 1.7  1.8 1.8  2.5 0.566
Maternal risk factors, n (%)
PROM >18 hr 3 (18.7) 22 (9.2) 0.214
Maternal fever 1 (6.3) 12 (5.0) 0.829
Maternal GBS screen positive 1 (6.3) 19 (8.0) 0.807
Maternal pyuria 0 (0) 6 (2.5) 0.521*
Meconium-stained amniotic fluid or chorioamnionitis 7 (43.8) 20 (8.7) <0.001*
Clinical presentations, n (%)
Respiratory rate >60 breaths/min 13 (8 1.3) 177 (74.1) 0.523
Severe chest retraction 11 (68.8) 109 (45.6) 0.073
Nasal flaring 8 (50.0) 81 (3 3.9) 0.191
Grunting 4 (25.0) 64 (2 6.8) 0.876
Convulsions 0 (0) 3 (1.3) 0.652
Bulging fontanelle 0 (0) 0 (0) NA
Pus draining from the ear 0 (0) 0 (0) NA
Redness a round umbilicus 0 (0) 1 (0.4) 0.795
Temperature >37.7C or <35.5C 0 (0) 12 (5.0) 0.359
Lethargic or unconscious or reduced movements 7 (43.8) 45 (1 8.8) 0.017
Not able to feed 9 (56.3) 80 (3 4.5) 0.064
No suckling at all 2 (12.5) 14 (5.9) 0.287
Cyanosis 3 (18.8) 60 (2 5.1) 0.568
Reduced digital capillary refill time 3 (18.8) 14 (5.9) 0.045*
Shock 1 (6.3) 9 (3.8) 0.620
Laboratory data, n (%)
Leukocytosis or leukopenia 9 (56.3) 90 (3 7.7) 0.140
Immature neutrophil/total neutrophil (I/T ratio) >0.2 1 (6.3) 20 (8.4) 0.762
CRP > 6 mg/L 4 (25.0) 23 (9.6) 0.053
IgM > 20 mg /dL 0 (0) 9 (3.8) 0.429
CSF study 3 (18.8) 33 (1 3.8) 0.583
Disease at admission, n (%)
Respiratory distress 11 (68.8) 167 (69.9) 0.924
Meconium aspiratory syndrome 3 (18.7) 10 (4.2) 0.010
Sepsis 1 (6.3) 33 (1 2.9) 0.389
Others* 1 (6.3) 29 (1 5.4) 0.479
Antibiotic used, n (%) 13 (8 1.3) 142 (58.9) 0.083
Original score, mean  SD 5.6  1.7 3.8  2.2 0.001*
Weighted score, mea n  SD 11.3  5.7 6.6  4.9 <0.001*
* Eight neonates were diagnosed with jaundice, 7 with apnea, 4 with GI problem, 3 were suspected of having congenital heart disease,
2 with birth injuries, 2 with neonatal abstinence syndrome, 2 with hypoglycemia, 1 with maternal acute myeloid leukemia, 1 with
thrombocytopenia, and 1 with maternal systemic lupus erythematosus.
250 Y.-N. Yang et alThere are several limitations of this study. First, a total
of 25 items were included in NBISS, so it took time to derive
a detailed history and perform complete physical exami-
nations. Some clinicians might not have completed theTable 3 The antibiotic usage rate in these two periods.
Observational period (n Z 250)
Antibiotic used, N (%) 237 (94.8%)NBISS on admission; the missed items were traced by the
researcher by the next day. In addition, regarding maternal
risk factors, we did not have the complete results of the
GBS screenings and urine examinations because GBSInterventional period (n Z 256) p value
155 (60.5%) <0.001
Strategy for reducing of antibiotic use 251screening is not a routine examination during prenatal
check-in in Taiwan, and some obstetric doctors do not
perform urine examinations before delivery. Third, NBISS is
just an additional tool used to guide the use of antibiotics,
so the clinicians decided if the patient needed antibiotics
based on their experience. There was no consistency
between clinicians in this study.
In summary, NBISS is a suitable and cheap method for
diagnosing BI in sick neonates, although it demonstrates
a low sensitivity. The rate of unnecessary antibiotic use and
the cost of healthcare might be reduced following the
introduction of NBISS. However, we have provided an
additional tool for helping clinicians decide the appropriate
use of antibiotics, and this might further reduce possible
bacterial resistance.Acknowledgments
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